The global major depressive disorder (MDD) treatment market is expected to experience steady growth, projected to develop at ...

Psilocybin-assisted therapy could potentially benefit up to 5.6 million Americans with major depressive disorder or treatment ...

Acupuncture. Ketamine infusions. "Electroshock" or electroconvulsive therapy. The existing treatment options for those ...

A light at the end of the dark tunnel of depression? Doctors commonly prescribe antidepressants to treat patients suffering ...

Bright light therapy, a standard treatment for seasonal depression, may also help people who experience depression year-round ...

Patients with non-seasonal depression who were treated with bright light therapy reported a 40% remission rate, according to a recent study.

Acupuncture. Ketamine infusions. “Electroshock” or electroconvulsive therapy. The existing treatment options for those ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional ...

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

The criteria for diagnosing SAD are similar to diagnosing major ... disorders. On average, SAD will last about five months of ...